Article details
Elon Musk, Sam Altman, and Chinese tech firms are competing to dominate the emerging $320 billion brain implant market, which enables thought-controlled devices. This sector, still in its early stages, has attracted significant attention from tech leaders and policymakers due to its transformative potential in healthcare and human-machine interaction. The race involves substantial R&D investments and regulatory lobbying, with implications for global tech leadership and market share. Investors should monitor regulatory developments and breakthroughs in neural interface technologies, which could redefine industries from healthcare to consumer electronics.
